Nadolol
35 NDCs across 11 manufacturers|35 Generic,0 Brand
Nadolol is used to treat angina pectoris, heart failure, hypertension and myocardial infarction, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Oct 31, 1993. FDA's Orange Book lists 30 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $15 million on Nadolol across 262,000 claims for 66,000 beneficiaries.
Nadolol is available as 35 NDCs from 11 manufacturers (35 generic, 0 brand), with NADAC prices from $0.15 to $0.59 per EA — the most expensive product costs about 4.1× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
35
35G / 0B
Manufacturers
11
competing in market
Price Spread
$0.15 – $0.59
per EA
7d Activity
avg -3.4% WoW · of 35 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
BluePoint Laboratories manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
beta-Adrenergic Blocker class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
11 manufacturers producing NADOLOL(4 pricing outliers)
Frequently Asked Questions
What is Nadolol used to treat?
Nadolol is used to treat angina pectoris, heart failure, hypertension and myocardial infarction, per the National Library of Medicine's MED-RT classification.
When did Nadolol become available as a generic?
FDA approved the first generic Nadolol (ANDA) on Oct 31, 1993. The Orange Book currently lists 30 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Nadolol?
In 2024, Medicare Part D spent $15 million on Nadolol across 262,000 claims for 66,000 beneficiaries.
How many Nadolol products are on the market?
The Nadolol drug market contains 35 NDCs from 11 manufacturers — 35 generic and 0 brand products.
What is the price range for Nadolol?
NADAC reference prices for Nadolol range from $0.1465 to $0.5944 per EA — the most expensive product costs about 4.1× the cheapest.
Which manufacturers make Nadolol?
11 manufacturers list Nadolol in NADAC. Ranked by number of NDCs, the largest are BluePoint Laboratories (6), VGYAAN Pharmaceuticals LLC (3), Cipla USA Inc. (3), Zydus Pharmaceuticals (USA) Inc. (3), Aurobindo Pharma Limited (3).
How has the price of Nadolol changed recently?
Over the past 7 days, 7 Nadolol NDCs rose and 16 fell, with a market-wide average change of -3.4%.